These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24153331)

  • 1. Determining minimal clinically important differences in Japanese cedar/cypress pollinosis patients.
    Higaki T; Okano M; Kariya S; Fujiwara T; Haruna T; Hirai H; Murai A; Gotoh M; Okubo K; Yonekura S; Okamoto Y; Nishizaki K
    Allergol Int; 2013 Dec; 62(4):487-93. PubMed ID: 24153331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract].
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T
    Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A MULTICENTER CLINICAL SURVEY ABOUT THE PREVALENCE OF JAPANESE CYPRESS POLLINOSIS AND THE EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH JAPANESE CEDAR POLLEN EXTRACT DURING JAPANESE CYPRESS POLLEN DISPERSAL PERIOD].
    Oka A; Yuta A; Okawa Y; Masuno S; Tsunoda T; Takahara E; Terada A; Kanai K; Nagakura H; Mimura H; Arao H; Ueyama S; Ueyama A; Tokuda R; Bamba H; Nakazato H; Nakazato M; Amesara R; Nakai S; Araki S; Sakaida M; Tokuriki M; Hama T; Chiba M; Ikeda H; Togawa A; Tsuzuki H; Hyo Y; Niitsu S; Ohkawa C; Nakamoto S; Takeo T; Kumanomidou H; Kanai K; Kitamura H; Sugiura R; Okano M
    Arerugi; 2023; 72(9):1138-1146. PubMed ID: 37967960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effects of immunotherapy on Japanese cedar pollinosis in the season of cedar and cypress pollination.
    Ito Y; Takahashi Y; Fujita T; Fukuyama S
    Auris Nasus Larynx; 1997 Apr; 24(2):163-70. PubMed ID: 9134139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of short-term oral immunotherapy with Cry j1-galactomannan conjugate on quality of life in Japanese cedar pollinosis patients: A prospective, randomized, open-label study.
    Murakami D; Sawatsubashi M; Kikkawa S; Ejima M; Saito A; Kato A; Komune S
    Auris Nasus Larynx; 2016 Feb; 43(1):50-5. PubMed ID: 26197940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early interventional treatment with intranasal corticosteroids compared with postonset treatment in pollinosis.
    Higaki T; Okano M; Makihara S; Fujiwara T; Haruna T; Noda Y; Kariya S; Nishizaki K
    Ann Allergy Asthma Immunol; 2012 Dec; 109(6):458-64. PubMed ID: 23176888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY WITH CEDAR POLLEN IN A YEAR OF MASSIVE CEDAR POLLEN DISPERSAL AND ITS EFFECT ON JAPANESE CYPRESS POLLINOSIS].
    Yuta A; Ogawa Y; Kozaki H; Shimizu T
    Arerugi; 2023; 72(10):1230-1239. PubMed ID: 38092399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment duration-dependent efficacy of Japanese cedar pollen sublingual immunotherapy: Evaluation of a phase II/III trial over three pollen dispersal seasons.
    Yonekura S; Gotoh M; Kaneko S; Kanazawa K; Takeuji Y; Okubo K; Okamoto Y
    Allergol Int; 2019 Oct; 68(4):494-505. PubMed ID: 31257168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fexofenadine improves the quality of life and work productivity in Japanese patients with seasonal allergic rhinitis during the peak cedar pollinosis season.
    Okubo K; Gotoh M; Shimada K; Ritsu M; Okuda M; Crawford B
    Int Arch Allergy Immunol; 2005 Feb; 136(2):148-54. PubMed ID: 15650312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cedar and cypress pollinosis and allergic rhinitis: quality of life effects of early intervention with leukotriene receptor antagonists.
    Sasaki K; Okamoto Y; Yonekura S; Okawa T; Horiguchi S; Chazono H; Hisamitsu M; Sakurai D; Hanazawa T; Okubo K
    Int Arch Allergy Immunol; 2009; 149(4):350-8. PubMed ID: 19295239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial.
    Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y
    Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized controlled trial of sublingual immunotherapy for Japanese cedar pollinosis.
    Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Yamamoto H; Kunii N; Sakurai D; Fujimura T; Nakazawa K; Yasueda H
    Int Arch Allergy Immunol; 2008; 146(1):76-84. PubMed ID: 18087165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis.
    Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N
    Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early interventional treatment with intranasal mometasone furoate in Japanese cedar/cypress pollinosis: a randomized placebo-controlled trial.
    Makihara S; Okano M; Fujiwara T; Kimura M; Higaki T; Haruna T; Noda Y; Kanai K; Kariya S; Nishizaki K
    Allergol Int; 2012 Jun; 61(2):295-304. PubMed ID: 22441634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Enhanced Clinical Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis in the Second Year of Treatment].
    Yuta A; Ogawa Y; Suzuki Y; Arikata M; Kozaki H; Shimizu T; Ohta N
    Nihon Jibiinkoka Gakkai Kaiho; 2017 Jan; 120(1):44-51. PubMed ID: 30035467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cedar and cypress pollen counts are associated with the prevalence of allergic diseases in Japanese schoolchildren.
    Yoshida K; Adachi Y; Akashi M; Itazawa T; Murakami Y; Odajima H; Ohya Y; Akasawa A
    Allergy; 2013 Jun; 68(6):757-63. PubMed ID: 23621581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between the SF-8 health status questionnaire and JRQLQ in patients with Japanese cedar pollinosis].
    Fujii T; Ogino S; Arimoto H; Irifune M; Iwata N; Ookawachi I; Kikumori H; Seo R; Takeda M; Tamaki A; Baba K; Nose M
    Arerugi; 2007 Feb; 56(2):109-17. PubMed ID: 17347597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline.
    Gotoh M; Yuta A; Okano M; Ohta N; Matsubara A; Okubo K
    Allergol Int; 2013 Jun; 62(2):181-9. PubMed ID: 23435559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [CLINICAL EFFICACY OF SUBLINGUAL IMMUNOTHERAPY IN THE THIRD TREATED YEAR WITH JAPANESE CEDAR POLLINOSIS IN 2017].
    Yuta A; Ogawa Y; Suzuki Y; Ogihara H; Ohta N; Kozaki H; Shimizu T
    Arerugi; 2017; 66(9):1172-1180. PubMed ID: 29129888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.